BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3046726)

  • 1. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Bacteroides encapsulation in the lethal synergy between Escherichia coli and Bacteroides species studied in a rat fibrin clot peritonitis model.
    Rotstein OD; Pruett TL; Wells CL; Simmons RL
    J Infect; 1987 Sep; 15(2):135-46. PubMed ID: 3312420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.
    Kelly MJ
    J Med Microbiol; 1978 Nov; 11(4):513-23. PubMed ID: 364068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardised and reproducible model of intraabdominal infection and abscess formation in rats.
    Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM
    Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.
    Verweij-van Vught AM; Namavar F; Sparrius M; Vel WA; MacLaren DM
    J Med Microbiol; 1985 Jun; 19(3):325-31. PubMed ID: 3892009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    J Med Vet Mycol; 1995; 33(1):49-52. PubMed ID: 7650578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM; Kim YJ; Cho YJ
    Scand J Infect Dis; 2000; 32(6):643-9. PubMed ID: 11200375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
    Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
    Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis.
    Otto BR; van Dooren SJ; Dozois CM; Luirink J; Oudega B
    Infect Immun; 2002 Jan; 70(1):5-10. PubMed ID: 11748157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic lethality in experimental infections with Escherichia coli and Bacteroides fragilis.
    Rodloff AC; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Oct; 258(1):112-9. PubMed ID: 6395577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; MacLaren DM
    J Med Microbiol; 1991 Jul; 35(1):18-22. PubMed ID: 2072375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental model of intraabdominal abscess in the rat.
    Fry DE; Garrison RN; Rink RD; Casey J; DeCamp MM; Richardson JD
    Adv Shock Res; 1982; 7():7-11. PubMed ID: 6753539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
    Lykkegaard Nielsen M; Asnaes S; Justesen T
    Scand J Gastroenterol; 1976; 11(3):263-72. PubMed ID: 775613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.